widespread use antigen psa revealed radiation therapy cures adenocarcinoma prostate frequently previously believed biologic factors complex nature disease technical factors geographic miss inadequate dose tumor volume affect ability radiation effectively treat patients prostate cancer improve treatment outcome patients virulent forms disease identified use prognostic markers psa membrane antigen antigen doubling time genetic markers NUMBER lipoxygenase p53 ploidy aid development treatments patients technical modifications increase total dose delivered prostate accuracy dose delivery brachytherapy proton therapy conformal radiation therapy used increase relative integral dose improved prostate targeting achieved use fiducial markers portal imaging endorectal magnetic resonance imaging high linear energy transfer radiation radiosensitizers altered fractionation used attempt increase biologic equivalent dose tumor lastly hormonal therapy chemotherapy shown decrease tumor burden improve local control methods improve outcome patients adenocarcinoma prostate work completed translate methods standards care references NUMBER prostate specific prostate specific prostate specific bcl NUMBER line